leisure time -WSS

leisure time

author：hotspot 2025-09-28 21:06:47 - browse：49224

The federal government is reforming methadone care for the first time in over two decades. But how far do the changes actually go?

To many methadone clinics, the Biden administration’s recent refresh of the rules governing opioid treatment programs represents an unprecedented opportunity to offer care that is more compassionate and responsive to patients’ needs. To many patient advocates, however, it simply nibbles around the edges.

The reality is likely somewhere in between: It will depend, in large part, on whether state-level regulators embrace the changes, and whether individual clinics actually implement them. In reform-oriented states, and at patient-centered clinics, the new rules could make a world of difference for people seeking addiction treatment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： PBM reforms clear House panel

hotspot

focus

WSS

Morphosys mixed study results for blood cancer drug

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

NYU radiologists take on the challenge of expensive MRI machines

Gain of function research would be limited under House proposal

Anthos stroke drug appears safer than common blood thinner

5 dead in mass shooting on Caribbean island of St. Vincent: Police

entertainment

leisure time

leisure time

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

How one medical school became remarkably diverse

Are infertility treatments 'essential' during the Covid

Guidelines to prevent youth baseball injuries need more muscle

'CMA Fest' 2023: How to watch, who is performing and more

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Morphosys mixed study results for blood cancer drug

BioMarin wins approval for gene therapy to treat hemophilia A

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

focus

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Congress must reauthorize a committee to support older Americans

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

hotspot

hotspot

focus

hotspot